HIPEC in India: The Complete Patient Guide (2026)
Complete 2026 guide to HIPEC surgery in India: who benefits, hospital stay, cost, recovery, outcomes. ESGO-certified Dr. Nishtha Tripathi Patel.
Ovarian Cancer
Complete Guide to Ovarian Cancer in India (2026)
Complete 2026 guide to ovarian cancer in India: symptoms, stages, diagnosis, surgery, HIPEC, PARP inhibitors, cost, survivorship. By ESGO-certified Dr. Nishtha Tripathi.
Ovarian Cancer Has Come Back: Can It Be Operated Again?
Can recurrent ovarian cancer be operated again? Learn when secondary CRS or repeat debulking may help, what surgery can involve and what alternatives exist.
Stage 3 Ovarian Cancer Treatment — Cytoreductive Surgery with HIPEC
Stage 3 ovarian cancer treatment: cytoreductive surgery, HIPEC, chemotherapy. ESGO-certified Dr. Nishtha Tripathi Patel, Ahmedabad.
Stage 4 Ovarian Cancer Treatment — Realistic Options & Outcomes
Stage 4 ovarian cancer treatment options in Ahmedabad — chemotherapy, debulking, maintenance therapy. Honest outlook. Dr. Nishtha Tripathi.
Stage 2 Ovarian Cancer Treatment — Surgery & Adjuvant Therapy
Stage 2 ovarian cancer treatment in Ahmedabad: cytoreductive surgery, chemotherapy. ESGO-certified Dr. Nishtha Tripathi Patel.
Stage 1 Ovarian Cancer Treatment in Ahmedabad — What to Expect
Stage 1 ovarian cancer treatment in Ahmedabad: surgery, adjuvant therapy, fertility-sparing options. ESGO-certified Dr. Nishtha Tripathi Patel.
9 Factors That Affect HIPEC Surgery Success
9 factors that affect HIPEC surgery success — surgeon experience, PCI score, completeness of cytoreduction. Dr. Nishtha Tripathi Patel, ESGO.
10 Hidden Signs of Ovarian Cancer Women Often Ignore
10 hidden signs of ovarian cancer women often ignore — bloating, fatigue, urinary changes. ESGO-certified Dr. Nishtha Tripathi. When to see a gynaec oncologist.
7 Myths About HIPEC Surgery, Debunked by a Gynaec Oncologist
7 common myths about HIPEC surgery in India debunked — cost, success rates, recovery. Dr. Nishtha Tripathi Patel, ESGO-certified gynaec oncosurgeon.